A supportive and performance-enhancing corporate culture is the basis for our success. We place particular importance on respectful interactions and view it as our responsibility, as company management, to actively promote and ensure this culture.

Since 2020, Dr. Friedrich Sernetz has served as CEO of the MiP Pharma Group. He is supported by CFO Patric Barra; in the areas of Business Development, Regulatory Affairs, and Pharmacovigilance, by Dr. Jürgen Mössinger; and in Marketing and Sales, by Jochen Steinhage.